COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says Yahoo! Voices
Categories
JOSSICA - The Journal of the Open Source Strategic Intelligence and Counterintelligence AnalysisJOSSICA - The Journal of the Open Source Strategic Intelligence and Counterintelligence Analysis - JOSSICA - jossica.com | The News And Times - TheNewsAndTimes.blogspot.com and TheNewsAndTimes.com